Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients

C. P. Peters; E. J. Eshuis; F. M. Toxopeus; M. E. Hellemons; J. M. Jansen; Gram D'Haens; P. Fockens; P. C. F. Stokkers; Hare Tuynman; A. A. van Bodegraven; C. Y. Ponsioen; G. U. T. Club North Holland

doi:10.1016/j.crohns.2014.01.012

Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients

C. P. Peters, E. J. Eshuis, F. M. Toxopeus, M. E. Hellemons, J. M. Jansen, Gram D'Haens, P. Fockens, P. C. F. Stokkers, Hare Tuynman, A. A. van Bodegraven, C. Y. Ponsioen, G. U. T. Club North Holland

Research output: Contribution to journal › Article › Academic › peer-review

75 Citations (Scopus)

Original language	English
Pages (from-to)	866-875
Number of pages	10
Journal	Journal of Crohn's and Colitis
Volume	8
Issue number	8
DOIs	https://doi.org/10.1016/j.crohns.2014.01.012
Publication status	Published - 2014
Externally published	Yes

Access to Document

10.1016/j.crohns.2014.01.012

Cite this

Peters, C. P., Eshuis, E. J., Toxopeus, F. M., Hellemons, M. E., Jansen, J. M., D'Haens, G., Fockens, P., Stokkers, P. C. F., Tuynman, H., van Bodegraven, A. A., Ponsioen, C. Y., & North Holland, G. U. T. C. (2014). Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients. Journal of Crohn's and Colitis, 8(8), 866-875. https://doi.org/10.1016/j.crohns.2014.01.012

@article{6a8e2139428c4d238e3d7ef421d36204,

title = "Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients",

author = "Peters, {C. P.} and Eshuis, {E. J.} and Toxopeus, {F. M.} and Hellemons, {M. E.} and Jansen, {J. M.} and Gram D'Haens and P. Fockens and Stokkers, {P. C. F.} and Hare Tuynman and {van Bodegraven}, {A. A.} and Ponsioen, {C. Y.} and {North Holland}, {G. U. T. Club}",

year = "2014",

doi = "10.1016/j.crohns.2014.01.012",

language = "English",

volume = "8",

pages = "866--875",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "8",

}

Peters, CP, Eshuis, EJ, Toxopeus, FM, Hellemons, ME, Jansen, JM, D'Haens, G, Fockens, P, Stokkers, PCF, Tuynman, H, van Bodegraven, AA, Ponsioen, CY & North Holland, GUTC 2014, 'Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients', Journal of Crohn's and Colitis, vol. 8, no. 8, pp. 866-875. https://doi.org/10.1016/j.crohns.2014.01.012

TY - JOUR

T1 - Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients

AU - Peters, C. P.

AU - Eshuis, E. J.

AU - Toxopeus, F. M.

AU - Hellemons, M. E.

AU - Jansen, J. M.

AU - D'Haens, Gram

AU - Fockens, P.

AU - Stokkers, P. C. F.

AU - Tuynman, Hare

AU - van Bodegraven, A. A.

AU - Ponsioen, C. Y.

AU - North Holland, G. U. T. Club

PY - 2014

Y1 - 2014

U2 - 10.1016/j.crohns.2014.01.012

DO - 10.1016/j.crohns.2014.01.012

M3 - Article

C2 - 24491515

SN - 1873-9946

VL - 8

SP - 866

EP - 875

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 8

ER -